logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yi He

Chinese Academy of Medical Sciences and Peking Union Medical College
H指数:8
被引数:570

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis

异基因造血干细胞移植后来特莫韦预防的最佳时机：来自真实世界时变暴露分析的研究启示

Bone Marrow Transplantation
IF5.2
2026-08-040
OA
Xueyao Li; Wenhao Wang; Ruixin Li; Jieya Luo; Xin Chen; Weihua Zhai; Rongli Zhang; Jialin Wei; Donglin Yang; Yi He; Aiming Pang; Sizhou Feng; Mingzhe Han; Yigeng Cao; Erlie Jiang
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML

CBFB::MYH11 MRD在第二次化疗周期后的检测：在低危急性髓系白血病异基因移植中的指导作用

Bone Marrow Transplantation
IF5.2
2026-05-140
PRE
Mingyang Wang; Guangji Zhang; Wenwen Guo; Haixiao Zhang; Jiaxin Cao; Jieya Luo; Miao Yang; Yigeng Cao; Fengjiao Wang; Rongli Zhang; Xin Chen; Weihua Zhai; Qiaoling Ma; Jialin Wei; Donglin Yang; Yi He; Aiming Pang; Sizhou Feng; Mingzhe Han; Yingchang Mi; Jianxiang Wang; Hui Wei; Erlie Jiang
FLT3-ITD with NPM1 and/or DNMT3A co-mutations in acute myeloid leukemia: prognostic significance and the role of maintenance therapy post-transplantation

FLT3-ITD突变伴随NPM1和/或DNMT3A共突变在急性髓系白血病中的预后意义及移植后维持治疗的作用

BLOOD SCIENCE
IF2.7
2025-12-010
PRE
Li, Ruixin; Cao, Jiaxin; Wang, Mingyang; Fan, Jinting; Yang, Yang; Gao, Hongye; Wang, Fengjiao; Yang, Donglin; Zhang, Rongli; Zhai, Weihua; Cao, Yigeng; Wei, Jialin; Pang, Aiming; He, Yi; Feng, Sizhou; Han, Mingzhe; Jiang, Erlie
Efficacy and Safety of the Third-Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation

第三代酪氨酸激酶抑制剂Olverembatinib与Inotuzumab Ozogamicin联合治疗成人费城染色体阳性急性淋巴细胞白血病患者的疗效与安全性：适用于难治/复发疾病或持续性微小残留病，作为桥接造血干细胞移植的方案。

American Journal of Hematology
IF9.9
2025-08-060
OAAI
Xiaoyu Zhang; Yigeng Cao; Jialin Wei; Weihua Zhai; Qiaoling Ma; Chen Liang; Xin Chen; Wenbin Cao; Donglin Yang; Aiming Pang; Yi He; Sizhou Feng; Mingzhe Han; Rongli Zhang; Erlie Jiang
Platelet transfusion refractoriness within one month post-hematopoietic stem cell transplantation does not impair survival in aplastic anemia patients after engraftment: a propensity score-matched analysis

造血干细胞移植后1个月内血小板输注抵抗在植入成功后不影响再生障碍性贫血患者的生存：一项倾向性评分匹配分析

Frontiers in Immunology
IF5.9
2025-07-260
OA
Yan Wang†; Yuanfeng Zhang†; Li Liu; Tingting Zhang; Jiali Sun; Xin Chen; Donglin Yang; Aiming Pang; Rongli Zhang; Qiaoling Ma; Weihua Zhai; Yi He; Jialin Wei; Yigeng Cao; Chen Liang; Erlie Jiang; MingZhe Han; Sizhou Feng
Timing of achieving MRD negativity for B-ALL patients with IKZF1 alterations in CR1 may dictate transplant decision: Autologous versus Allogeneic HSCT

B-ALL患者CR1期IKZF1基因突变者达到微小残留病（MRD）阴性的时间，可能决定移植决策：自体移植与异基因造血干细胞移植（HSCT）。

BONE MARROW TRANSPLANTATION
IF5.2
2025-05-210
PRE
Wang, Jiali; Ma, Xiaoxiao; Gao, Hongye; Lv, Mengnan; Zhai, Weihua; Wei, Jialin; Ma, Qiaoling; Chen, Xin; Cao, Yigeng; Cao, Wenbin; Liang, Chen; Yang, Donglin; Pang, Aiming; He, Yi; Feng, Sizhou; Han, Mingzhe; Zhang, Rongli; Jiang, Erlie
Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia
FRONTIERS IN IMMUNOLOGY
IF5.9
2025-01-080
OAAI
Wang, Mingyang; Chen, Shulian; Zhang, Qiuqiu; Yuan, Linyu; Wang, Xue; Zhang, Junshi; Zhang, Xiaoyu; Cao, Yigeng; Li, Dongmei; Lu, Xinxiao; Wang, Meijiao; Jiang, Xiaosi; Zhang, Rongli; Chen, Xin; Ma, Qiaoling; Wei, Jialin; Yang, Donglin; He, Yi; Pang, Aiming; Feng, Sizhou; Han, Mingzhe; Zhai, Weihua; Zhao, Xingli; Jiang, Erlie
Application patterns and outcomes of hematopoietic stem cell transplantation in peripheral T-cell lymphoma patients: a multicenter real-world study in China

造血干细胞移植在外周T细胞淋巴瘤患者中的应用模式和结局: 一项多中心真实世界的中国研究

hematology oncology
IF13.5
2024-08-240
OAAI
Gao, Hongye; Zhang, Zhuoxin; Wang, Jiali; Jia, Yannan; Zheng, Yawei; Pei, Xiaolei; Zhai, Weihua; Zhang, Rongli; Chen, Xin; Ma, Qiaoling; Wei, Jialin; Yang, Donglin; Pang, Aiming; He, Yi; Feng, Sizhou; Zhang, Hao; Du, Xin; Song, Xianmin; Liu, Yao; Zou, Dehui; Jiang, Erlie

研究方向

暂未获取到该数据
A
Aiming Pang
H 指数:17论文数:208被引数:1,214
D
Donglin Yang
H 指数:19论文数:178被引数:2,092
J
Jialin Wei
H 指数:13论文数:185被引数:786
Y
Yigeng Cao
H 指数:8论文数:73被引数:241
E
Erlie Jiang
H 指数:28论文数:532被引数:3,310
Q
Qiaoling Ma
H 指数:13论文数:158被引数:625
E
Erlie Jiang
H 指数:2论文数:50被引数:29
W
Weihua Zhai
H 指数:14论文数:150被引数:717
R
Rongli Zhang
H 指数:3论文数:21被引数:31
S
Sizhou Feng
H 指数:5论文数:38被引数:125